CLINICAL_TRIALS
trial_result
· 2017-03-13
Clinical Trial Update: Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer [Phase 2]
Summary
Phase 2 trial of acolbifene in premenopausal women at high risk for breast cancer completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-13